InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Mandelia Ashish, Vice-Président, Contrôleur. Officer active across 1 company, notably Mersana Therapeutics, Inc.. In total, 10 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €22k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 15 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
4,519 shares0Common StockSEC:0001104659-25-004597:0
4,783 shares0Common StockSEC:0001104659-25-004185:0
2,646 shares0Common StockSEC:0001104659-25-003879:0
30,000 shares0Common StockSEC:0001104659-24-106748:0
2,645 shares0Common StockSEC:0001104659-24-004549:0
4,784 shares0Common StockSEC:0001104659-23-004743:0
5,353 sharesCommon StockSEC:0001104659-22-005555
5,353 sharesCommon StockSEC:0001104659-22-005555:0
942 shares@ US$13.6050.0% of flowCommon StockSEC:0001104659-21-088909:0
942 shares@ US$13.6050.0% of flowCommon StockSEC:0001104659-21-088909
10 of 10 declarations
About Mandelia Ashish
Mandelia Ashish is the VP and Controller at Mersana Therapeutics, Inc. In this role, he is responsible for financial management and compliance, ensuring that the company adheres to accounting and regulatory standards. His expertise contributes to the financial health of the organization.
